Assessing the Immunological Safety of Silk Fibroin Nanoparticles: An In Vitro Study With Primary Human Immune Cells.

Rodrigues B, Ramos AB, Silva S, Pereira RFP, Fonseca AC, Serra AC, Coelho JFJ, Cruz MT, Fonseca RG

Open source

DOI
10.1002/adhm.71687
Published
2026 Sep 8
Container
Advanced healthcare materials
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/adhm.71687,
  title = {Assessing the Immunological Safety of Silk Fibroin Nanoparticles: An In Vitro Study With Primary Human Immune Cells.},
  author = {Rodrigues B and Ramos AB and Silva S and Pereira RFP and Fonseca AC and Serra AC and Coelho JFJ and Cruz MT and Fonseca RG},
  year = {2026},
  journal = {Advanced healthcare materials},
  doi = {10.1002/adhm.71687},
  url = {https://doi.org/10.1002/adhm.71687}
}

RIS

TY  - JOUR
TI  - Assessing the Immunological Safety of Silk Fibroin Nanoparticles: An In Vitro Study With Primary Human Immune Cells.
AU  - Rodrigues B
AU  - Ramos AB
AU  - Silva S
AU  - Pereira RFP
AU  - Fonseca AC
AU  - Serra AC
AU  - Coelho JFJ
AU  - Cruz MT
AU  - Fonseca RG
PY  - 2026
JO  - Advanced healthcare materials
DO  - 10.1002/adhm.71687
UR  - https://doi.org/10.1002/adhm.71687
ER  - 

APA

B, R., AB, R., S, S., RFP, P., AC, F., AC, S., JFJ, C., MT, C., & RG, F. (2026). Assessing the Immunological Safety of Silk Fibroin Nanoparticles: An In Vitro Study With Primary Human Immune Cells.. Advanced healthcare materials. https://doi.org/10.1002/adhm.71687

Source records